Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000153756 | SCV000248554 | benign | not specified | 2013-10-30 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000153756 | SCV000257925 | likely benign | not specified | 2015-07-10 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000714693 | SCV000845415 | benign | POLG-Related Spectrum Disorders | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312681 | SCV000846208 | benign | Inborn genetic diseases | 2016-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Wong Mito Lab, |
RCV000758545 | SCV000887271 | benign | Progressive sclerosing poliodystrophy | 2018-10-01 | criteria provided, single submitter | clinical testing | The NM_002693.2:c.156_158dup (NP_002684.1:p.Gln53_Gln54insGln) [GRCH38: NC_000015.10:g.89333627_89333629dup] variant in POLG gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 4A (Alpers type). BS2:Observation of the variant in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 4A (Alpers type). BP4:Computational evidence/predictors indicate no impact on the POLG structure, function, or protein-protein interaction. Based on the evidence criteria codes applied, the variant is suggested to be Benign. |
Labcorp Genetics |
RCV000758545 | SCV001717997 | benign | Progressive sclerosing poliodystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676330 | SCV001832966 | benign | not provided | 2020-06-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23066759, 29190809) |
ARUP Laboratories, |
RCV000676330 | SCV002058045 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847785 | SCV002105551 | benign | Hereditary spastic paraplegia | 2021-12-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492575 | SCV002795443 | likely benign | Progressive sclerosing poliodystrophy; Mitochondrial DNA depletion syndrome 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b | 2021-08-23 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV003993835 | SCV004812617 | benign | Recessive mitochondrial ataxia syndrome | 2023-06-06 | criteria provided, single submitter | clinical testing | Allele frequency in gnomAD v3.1 is >5% in the African/African American population dataset. |
Eurofins Ntd Llc |
RCV000153756 | SCV000203330 | benign | not specified | 2014-02-19 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676330 | SCV000802100 | benign | not provided | 2016-02-22 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000676330 | SCV001799438 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000153756 | SCV001806793 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000153756 | SCV001930110 | benign | not specified | no assertion criteria provided | clinical testing |